Skip to content

Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone

A Multi-center, Open-labeled Study of the Long-term Safety and Efficacy of Lubiprostone in Patients With Opioid-induced Bowel Dysfunction

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00620061
Enrollment
439
Registered
2008-02-21
Start date
2007-12-31
Completion date
2009-09-30
Last updated
2020-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Opioid-Induced Bowel Dysfunction

Brief summary

The purpose of this study is to evaluate the long-term safety and efficacy of lubiprostone administration in participants with opioid-induced bowel dysfunction.

Interventions

DRUGLubiprostone 24

24 mcg capsules for oral administration

Sponsors

Sucampo Pharma Americas, LLC
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Has completed 12 weeks of blinded treatment in NCT00595946 or NCT00597428 * Will continue to be treated consistently for chronic, non-cancer-related pain with any full agonist opiate and will continue opiate therapy for the duration of the study * Willing to continue to abstain from use of disallowed medications as defined per protocol

Exclusion criteria

* Has newly diagnosed impaired renal function identified at the Screening Visit \[i.e., serum creatinine concentration \> 1.8 milligrams per deciliter (mg/dL)\] * Has experienced an unexplained and/or clinically significant weight loss defined as \> 5% within 90 days prior to Screening Visit. * Has plans to participate in another trial with an investigational drug or device during the course of the extension study

Design outcomes

Primary

MeasureTime frameDescription
Mean Weekly Spontaneous Bowel Movements (SBMs) Per MonthBaseline, Months 1, 2, 3, 4, 5, 6, 7, 8, and 9A Spontaneous Bowel Movement (SBM) is defined as any bowel movement (BM) that did not occur within the 24-hour period following use of a rescue medication.
Mean Weekly Bowel Movements (BMs) Per MonthBaseline, Months 1, 2, 3, 4, 5, 6, 7, 8, and 9A Bowel Movement (BM) is defined as any BM (whether spontaneous or not)

Secondary

MeasureTime frameDescription
Stool Consistency of Spontaneous Bowel Movements by MonthBaseline, Months 1, 2, 3, 4, 5, 6, 7, 8, and 9Participants rate each spontaneous bowel movement on a scale where 0 = very loose, 1 = loose, 2 = normal, 3 = hard, 4 = very hard (little balls) The highest score is 4, but the best score is 2.
Constipation Severity by MonthBaseline, Months 1, 2, 3, 4, 5, 6, 7, 8, and 9Participants rate the severity of their constipation on a scale where 0 = none, 1 = mild, 2 = moderate, 3 = severe, 4 = very severe. The highest score is 4, but the best score is 0.
Abdominal Bloating by MonthBaseline, Months 1, 2, 3, 4, 5, 6, 7, 8, and 9Participants rate their bloating on a scale where 0 = none, 1 = mild, 2 = moderate, 3 = severe, 4 = very severe. The highest score is 4, but the best score is 0.
Abdominal Discomfort by MonthBaseline, Months 1, 2, 3, 4, 5, 6, 7, 8, and 9Participants rate their abdominal discomfort on a scale where 0 = none, 1 = mild, 2 = moderate, 3 = severe, 4 = very severe. The highest score is 4, but the best score is 0.
Number of Participants Classified as Monthly RespondersMonths 1, 2, 3, 4, 5, 6, 7, 8, and 9A weekly SBM frequency rate is calculated as (168 x Number of SBMs / Number of hours observed). A participant with an SBM frequency rate between 3 and 4 was considered a moderate responder. A subject with an SBM frequency rate higher than 4 was considered a full responder. If a subject was a moderate responder or full responder for at least half the weeks in a month, then he or she was considered a monthly responder.
Treatment Effectiveness by MonthMonths 1, 2, 3, 4, 5, 6, 7, 8, and 9Participants rate treatment effectiveness on a scale where 0 = not at all effective, 1 = a little bit effective, 2 = moderately effective, 3 = quite a bit effective, 4 = extremely effective. The highest and best score is 4.
Mean Weekly Complete SBMs by MonthMonths 1, 2, 3, 4, 5, 6, 7, 8, and 9Participants rate each SBM as complete if their bowels feel completely empty after the SBM
Mean Weekly Complete BMs by MonthMonths 1, 2, 3, 4, 5, 6, 7, 8, and 9Participants rate each BM as complete if their bowels feel completely empty after the BM
Bowel Habit Regularity by MonthBaseline, Months 1, 2, 3, 4, 5, 6, 7, 8, and 9Participants rate their bowel habit regularity on a balanced scale of 1 to 7 where 1=Very Regular and 7=Very Irregular. The highest score is 7, but the best score is 1.
Straining Associated With Spontaneous Bowel Movements by MonthBaseline, Months 1, 2, 3, 4, 5, 6, 7, 8, and 9Participants rate the straining associated with the SBM on a scale where 0 = none, 1 = mild, 2 = moderate, 3 = severe, 4 = very severe The highest score is 4, and lower scores are better.

Countries

Canada, United States

Participant flow

Recruitment details

Participants were enrolled from 4 December 2007 to 29 September 2009 at 137 recruitment sites in the United States (n=134) and Canada (n=3)

Participants by arm

ArmCount
Lubiprostone
Lubiprostone: 24 mcg capsules twice daily (BID) for 36 weeks
439
Total439

Baseline characteristics

CharacteristicLubiprostone
Age, Continuous49.8 Years
STANDARD_DEVIATION 9.99
Region of Enrollment
Canada
3 participants
Region of Enrollment
United States
436 participants
Sex: Female, Male
Female
263 Participants
Sex: Female, Male
Male
176 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
1 / 439
other
Total, other adverse events
100 / 439
serious
Total, serious adverse events
34 / 439

Outcome results

Primary

Mean Weekly Bowel Movements (BMs) Per Month

A Bowel Movement (BM) is defined as any BM (whether spontaneous or not)

Time frame: Baseline, Months 1, 2, 3, 4, 5, 6, 7, 8, and 9

Population: Intent-to-treat population with evaluable BM data during the given month

ArmMeasureGroupValue (MEAN)Dispersion
All ParticipantsMean Weekly Bowel Movements (BMs) Per MonthMonth 25.0 Weekly BMsStandard Deviation 2.63
All ParticipantsMean Weekly Bowel Movements (BMs) Per MonthBaseline2.4 Weekly BMsStandard Deviation 1.38
All ParticipantsMean Weekly Bowel Movements (BMs) Per MonthMonth 15.0 Weekly BMsStandard Deviation 2.73
All ParticipantsMean Weekly Bowel Movements (BMs) Per MonthMonth 35.2 Weekly BMsStandard Deviation 2.7
All ParticipantsMean Weekly Bowel Movements (BMs) Per MonthMonth 45.1 Weekly BMsStandard Deviation 2.67
All ParticipantsMean Weekly Bowel Movements (BMs) Per MonthMonth 55.1 Weekly BMsStandard Deviation 2.79
All ParticipantsMean Weekly Bowel Movements (BMs) Per MonthMonth 65.1 Weekly BMsStandard Deviation 2.85
All ParticipantsMean Weekly Bowel Movements (BMs) Per MonthMonth 75.2 Weekly BMsStandard Deviation 2.9
All ParticipantsMean Weekly Bowel Movements (BMs) Per MonthMonth 85.4 Weekly BMsStandard Deviation 2.88
All ParticipantsMean Weekly Bowel Movements (BMs) Per MonthMonth 95.3 Weekly BMsStandard Deviation 3.15
Primary

Mean Weekly Spontaneous Bowel Movements (SBMs) Per Month

A Spontaneous Bowel Movement (SBM) is defined as any bowel movement (BM) that did not occur within the 24-hour period following use of a rescue medication.

Time frame: Baseline, Months 1, 2, 3, 4, 5, 6, 7, 8, and 9

Population: Intent-to-treat population with evaluable SBM data during the given month

ArmMeasureGroupValue (MEAN)Dispersion
All ParticipantsMean Weekly Spontaneous Bowel Movements (SBMs) Per MonthBaseline1.4 Weekly SBMsStandard Deviation 0.98
All ParticipantsMean Weekly Spontaneous Bowel Movements (SBMs) Per MonthMonth 14.9 Weekly SBMsStandard Deviation 2.72
All ParticipantsMean Weekly Spontaneous Bowel Movements (SBMs) Per MonthMonth 24.9 Weekly SBMsStandard Deviation 2.62
All ParticipantsMean Weekly Spontaneous Bowel Movements (SBMs) Per MonthMonth 35.0 Weekly SBMsStandard Deviation 2.76
All ParticipantsMean Weekly Spontaneous Bowel Movements (SBMs) Per MonthMonth 45.0 Weekly SBMsStandard Deviation 2.71
All ParticipantsMean Weekly Spontaneous Bowel Movements (SBMs) Per MonthMonth 55.0 Weekly SBMsStandard Deviation 2.82
All ParticipantsMean Weekly Spontaneous Bowel Movements (SBMs) Per MonthMonth 65.0 Weekly SBMsStandard Deviation 2.86
All ParticipantsMean Weekly Spontaneous Bowel Movements (SBMs) Per MonthMonth 75.1 Weekly SBMsStandard Deviation 2.93
All ParticipantsMean Weekly Spontaneous Bowel Movements (SBMs) Per MonthMonth 85.3 Weekly SBMsStandard Deviation 2.91
All ParticipantsMean Weekly Spontaneous Bowel Movements (SBMs) Per MonthMonth 95.2 Weekly SBMsStandard Deviation 3.19
Secondary

Abdominal Bloating by Month

Participants rate their bloating on a scale where 0 = none, 1 = mild, 2 = moderate, 3 = severe, 4 = very severe. The highest score is 4, but the best score is 0.

Time frame: Baseline, Months 1, 2, 3, 4, 5, 6, 7, 8, and 9

Population: Intent-to-treat with evaluable data at the given time point

ArmMeasureGroupValue (MEAN)Dispersion
All ParticipantsAbdominal Bloating by MonthBaseline2.2 score on a scaleStandard Deviation 0.74
All ParticipantsAbdominal Bloating by MonthMonth 11.6 score on a scaleStandard Deviation 0.88
All ParticipantsAbdominal Bloating by MonthMonth 21.5 score on a scaleStandard Deviation 0.9
All ParticipantsAbdominal Bloating by MonthMonth 31.5 score on a scaleStandard Deviation 0.91
All ParticipantsAbdominal Bloating by MonthMonth 41.5 score on a scaleStandard Deviation 0.9
All ParticipantsAbdominal Bloating by MonthMonth 51.5 score on a scaleStandard Deviation 0.92
All ParticipantsAbdominal Bloating by MonthMonth 61.5 score on a scaleStandard Deviation 0.91
All ParticipantsAbdominal Bloating by MonthMonth 71.5 score on a scaleStandard Deviation 0.93
All ParticipantsAbdominal Bloating by MonthMonth 81.5 score on a scaleStandard Deviation 0.95
All ParticipantsAbdominal Bloating by MonthMonth 91.5 score on a scaleStandard Deviation 0.95
Secondary

Abdominal Discomfort by Month

Participants rate their abdominal discomfort on a scale where 0 = none, 1 = mild, 2 = moderate, 3 = severe, 4 = very severe. The highest score is 4, but the best score is 0.

Time frame: Baseline, Months 1, 2, 3, 4, 5, 6, 7, 8, and 9

Population: Intent-to-treat with evaluable data at the given time point

ArmMeasureGroupValue (MEAN)Dispersion
All ParticipantsAbdominal Discomfort by MonthBaseline2.2 score on a scaleStandard Deviation 0.67
All ParticipantsAbdominal Discomfort by MonthMonth 11.5 score on a scaleStandard Deviation 0.82
All ParticipantsAbdominal Discomfort by MonthMonth 21.4 score on a scaleStandard Deviation 0.82
All ParticipantsAbdominal Discomfort by MonthMonth 31.4 score on a scaleStandard Deviation 0.84
All ParticipantsAbdominal Discomfort by MonthMonth 41.4 score on a scaleStandard Deviation 0.83
All ParticipantsAbdominal Discomfort by MonthMonth 51.4 score on a scaleStandard Deviation 0.86
All ParticipantsAbdominal Discomfort by MonthMonth 61.4 score on a scaleStandard Deviation 0.85
All ParticipantsAbdominal Discomfort by MonthMonth 71.4 score on a scaleStandard Deviation 0.85
All ParticipantsAbdominal Discomfort by MonthMonth 81.4 score on a scaleStandard Deviation 0.89
All ParticipantsAbdominal Discomfort by MonthMonth 91.4 score on a scaleStandard Deviation 0.91
Secondary

Bowel Habit Regularity by Month

Participants rate their bowel habit regularity on a balanced scale of 1 to 7 where 1=Very Regular and 7=Very Irregular. The highest score is 7, but the best score is 1.

Time frame: Baseline, Months 1, 2, 3, 4, 5, 6, 7, 8, and 9

Population: Intent-to-treat with evaluable data at the given time point

ArmMeasureGroupValue (MEAN)Dispersion
All ParticipantsBowel Habit Regularity by MonthBaseline4.7 score on a scaleStandard Deviation 1.59
All ParticipantsBowel Habit Regularity by MonthMonth 13.6 score on a scaleStandard Deviation 1.39
All ParticipantsBowel Habit Regularity by MonthMonth 23.6 score on a scaleStandard Deviation 1.38
All ParticipantsBowel Habit Regularity by MonthMonth 33.5 score on a scaleStandard Deviation 1.42
All ParticipantsBowel Habit Regularity by MonthMonth 43.5 score on a scaleStandard Deviation 1.45
All ParticipantsBowel Habit Regularity by MonthMonth 53.5 score on a scaleStandard Deviation 1.47
All ParticipantsBowel Habit Regularity by MonthMonth 63.5 score on a scaleStandard Deviation 1.5
All ParticipantsBowel Habit Regularity by MonthMonth 73.5 score on a scaleStandard Deviation 1.47
All ParticipantsBowel Habit Regularity by MonthMonth 83.4 score on a scaleStandard Deviation 1.49
All ParticipantsBowel Habit Regularity by MonthMonth 93.4 score on a scaleStandard Deviation 1.51
Secondary

Constipation Severity by Month

Participants rate the severity of their constipation on a scale where 0 = none, 1 = mild, 2 = moderate, 3 = severe, 4 = very severe. The highest score is 4, but the best score is 0.

Time frame: Baseline, Months 1, 2, 3, 4, 5, 6, 7, 8, and 9

Population: Intent-to-treat with evaluable scores at the given time point

ArmMeasureGroupValue (MEAN)Dispersion
All ParticipantsConstipation Severity by MonthBaseline2.4 score on a scaleStandard Deviation 0.72
All ParticipantsConstipation Severity by MonthMonth 11.5 score on a scaleStandard Deviation 0.93
All ParticipantsConstipation Severity by MonthMonth 21.5 score on a scaleStandard Deviation 0.94
All ParticipantsConstipation Severity by MonthMonth 31.5 score on a scaleStandard Deviation 0.93
All ParticipantsConstipation Severity by MonthMonth 41.5 score on a scaleStandard Deviation 0.96
All ParticipantsConstipation Severity by MonthMonth 51.4 score on a scaleStandard Deviation 0.95
All ParticipantsConstipation Severity by MonthMonth 61.4 score on a scaleStandard Deviation 0.94
All ParticipantsConstipation Severity by MonthMonth 71.4 score on a scaleStandard Deviation 0.94
All ParticipantsConstipation Severity by MonthMonth 81.4 score on a scaleStandard Deviation 0.97
All ParticipantsConstipation Severity by MonthMonth 91.4 score on a scaleStandard Deviation 0.99
Secondary

Mean Weekly Complete BMs by Month

Participants rate each BM as complete if their bowels feel completely empty after the BM

Time frame: Months 1, 2, 3, 4, 5, 6, 7, 8, and 9

Population: Intent-to-treat with evaluable data at the time point

ArmMeasureGroupValue (MEAN)Dispersion
All ParticipantsMean Weekly Complete BMs by MonthMonth 13.1 Weekly Complete BMsStandard Deviation 2.26
All ParticipantsMean Weekly Complete BMs by MonthMonth 23.4 Weekly Complete BMsStandard Deviation 2.28
All ParticipantsMean Weekly Complete BMs by MonthMonth 33.6 Weekly Complete BMsStandard Deviation 2.46
All ParticipantsMean Weekly Complete BMs by MonthMonth 43.7 Weekly Complete BMsStandard Deviation 2.38
All ParticipantsMean Weekly Complete BMs by MonthMonth 53.8 Weekly Complete BMsStandard Deviation 2.65
All ParticipantsMean Weekly Complete BMs by MonthMonth 63.8 Weekly Complete BMsStandard Deviation 2.62
All ParticipantsMean Weekly Complete BMs by MonthMonth 73.8 Weekly Complete BMsStandard Deviation 2.78
All ParticipantsMean Weekly Complete BMs by MonthMonth 83.9 Weekly Complete BMsStandard Deviation 2.69
All ParticipantsMean Weekly Complete BMs by MonthMonth 94.1 Weekly Complete BMsStandard Deviation 2.96
Secondary

Mean Weekly Complete SBMs by Month

Participants rate each SBM as complete if their bowels feel completely empty after the SBM

Time frame: Months 1, 2, 3, 4, 5, 6, 7, 8, and 9

Population: Intent-to-treat with evaluable data at the time point

ArmMeasureGroupValue (MEAN)Dispersion
All ParticipantsMean Weekly Complete SBMs by MonthMonth 13.1 Weekly Complete SBMsStandard Deviation 2.26
All ParticipantsMean Weekly Complete SBMs by MonthMonth 23.4 Weekly Complete SBMsStandard Deviation 2.27
All ParticipantsMean Weekly Complete SBMs by MonthMonth 33.6 Weekly Complete SBMsStandard Deviation 2.47
All ParticipantsMean Weekly Complete SBMs by MonthMonth 43.6 Weekly Complete SBMsStandard Deviation 2.4
All ParticipantsMean Weekly Complete SBMs by MonthMonth 53.7 Weekly Complete SBMsStandard Deviation 2.64
All ParticipantsMean Weekly Complete SBMs by MonthMonth 63.7 Weekly Complete SBMsStandard Deviation 2.62
All ParticipantsMean Weekly Complete SBMs by MonthMonth 73.9 Weekly Complete SBMsStandard Deviation 2.79
All ParticipantsMean Weekly Complete SBMs by MonthMonth 83.9 Weekly Complete SBMsStandard Deviation 2.69
All ParticipantsMean Weekly Complete SBMs by MonthMonth 94.2 Weekly Complete SBMsStandard Deviation 2.95
Secondary

Number of Participants Classified as Monthly Responders

A weekly SBM frequency rate is calculated as (168 x Number of SBMs / Number of hours observed). A participant with an SBM frequency rate between 3 and 4 was considered a moderate responder. A subject with an SBM frequency rate higher than 4 was considered a full responder. If a subject was a moderate responder or full responder for at least half the weeks in a month, then he or she was considered a monthly responder.

Time frame: Months 1, 2, 3, 4, 5, 6, 7, 8, and 9

Population: Intent-to-treat

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
All ParticipantsNumber of Participants Classified as Monthly RespondersMonth 1322 Participants
All ParticipantsNumber of Participants Classified as Monthly RespondersMonth 2323 Participants
All ParticipantsNumber of Participants Classified as Monthly RespondersMonth 3291 Participants
All ParticipantsNumber of Participants Classified as Monthly RespondersMonth 4270 Participants
All ParticipantsNumber of Participants Classified as Monthly RespondersMonth 5259 Participants
All ParticipantsNumber of Participants Classified as Monthly RespondersMonth 6250 Participants
All ParticipantsNumber of Participants Classified as Monthly RespondersMonth 7239 Participants
All ParticipantsNumber of Participants Classified as Monthly RespondersMonth 8233 Participants
All ParticipantsNumber of Participants Classified as Monthly RespondersMonth 9202 Participants
Secondary

Stool Consistency of Spontaneous Bowel Movements by Month

Participants rate each spontaneous bowel movement on a scale where 0 = very loose, 1 = loose, 2 = normal, 3 = hard, 4 = very hard (little balls) The highest score is 4, but the best score is 2.

Time frame: Baseline, Months 1, 2, 3, 4, 5, 6, 7, 8, and 9

Population: Intent-to-treat with evaluable data at the given time point

ArmMeasureGroupValue (MEAN)Dispersion
All ParticipantsStool Consistency of Spontaneous Bowel Movements by MonthBaseline3.0 score on a scaleStandard Deviation 0.84
All ParticipantsStool Consistency of Spontaneous Bowel Movements by MonthMonth 12.3 score on a scaleStandard Deviation 0.75
All ParticipantsStool Consistency of Spontaneous Bowel Movements by MonthMonth 22.2 score on a scaleStandard Deviation 0.73
All ParticipantsStool Consistency of Spontaneous Bowel Movements by MonthMonth 32.2 score on a scaleStandard Deviation 0.74
All ParticipantsStool Consistency of Spontaneous Bowel Movements by MonthMonth 42.2 score on a scaleStandard Deviation 0.72
All ParticipantsStool Consistency of Spontaneous Bowel Movements by MonthMonth 52.2 score on a scaleStandard Deviation 0.7
All ParticipantsStool Consistency of Spontaneous Bowel Movements by MonthMonth 62.2 score on a scaleStandard Deviation 0.68
All ParticipantsStool Consistency of Spontaneous Bowel Movements by MonthMonth 72.2 score on a scaleStandard Deviation 0.7
All ParticipantsStool Consistency of Spontaneous Bowel Movements by MonthMonth 82.2 score on a scaleStandard Deviation 0.66
All ParticipantsStool Consistency of Spontaneous Bowel Movements by MonthMonth 92.2 score on a scaleStandard Deviation 0.7
Secondary

Straining Associated With Spontaneous Bowel Movements by Month

Participants rate the straining associated with the SBM on a scale where 0 = none, 1 = mild, 2 = moderate, 3 = severe, 4 = very severe The highest score is 4, and lower scores are better.

Time frame: Baseline, Months 1, 2, 3, 4, 5, 6, 7, 8, and 9

Population: Intent-to-treat with evaluable data at the given time point

ArmMeasureGroupValue (MEAN)Dispersion
All ParticipantsStraining Associated With Spontaneous Bowel Movements by MonthBaseline2.7 score on a scaleStandard Deviation 0.87
All ParticipantsStraining Associated With Spontaneous Bowel Movements by MonthMonth 11.7 score on a scaleStandard Deviation 0.85
All ParticipantsStraining Associated With Spontaneous Bowel Movements by MonthMonth 21.7 score on a scaleStandard Deviation 0.85
All ParticipantsStraining Associated With Spontaneous Bowel Movements by MonthMonth 31.6 score on a scaleStandard Deviation 0.84
All ParticipantsStraining Associated With Spontaneous Bowel Movements by MonthMonth 41.7 score on a scaleStandard Deviation 0.83
All ParticipantsStraining Associated With Spontaneous Bowel Movements by MonthMonth 51.6 score on a scaleStandard Deviation 0.85
All ParticipantsStraining Associated With Spontaneous Bowel Movements by MonthMonth 61.7 score on a scaleStandard Deviation 0.84
All ParticipantsStraining Associated With Spontaneous Bowel Movements by MonthMonth 71.7 score on a scaleStandard Deviation 0.86
All ParticipantsStraining Associated With Spontaneous Bowel Movements by MonthMonth 81.6 score on a scaleStandard Deviation 0.87
All ParticipantsStraining Associated With Spontaneous Bowel Movements by MonthMonth 91.6 score on a scaleStandard Deviation 0.92
Secondary

Treatment Effectiveness by Month

Participants rate treatment effectiveness on a scale where 0 = not at all effective, 1 = a little bit effective, 2 = moderately effective, 3 = quite a bit effective, 4 = extremely effective. The highest and best score is 4.

Time frame: Months 1, 2, 3, 4, 5, 6, 7, 8, and 9

Population: Intent-to-treat with evaluable data at the given time point

ArmMeasureGroupValue (MEAN)Dispersion
All ParticipantsTreatment Effectiveness by MonthMonth 12.1 score on a scaleStandard Deviation 0.98
All ParticipantsTreatment Effectiveness by MonthMonth 22.1 score on a scaleStandard Deviation 1.02
All ParticipantsTreatment Effectiveness by MonthMonth 32.2 score on a scaleStandard Deviation 1.04
All ParticipantsTreatment Effectiveness by MonthMonth 42.2 score on a scaleStandard Deviation 1.05
All ParticipantsTreatment Effectiveness by MonthMonth 52.2 score on a scaleStandard Deviation 1.05
All ParticipantsTreatment Effectiveness by MonthMonth 62.2 score on a scaleStandard Deviation 1.04
All ParticipantsTreatment Effectiveness by MonthMonth 72.3 score on a scaleStandard Deviation 1.05
All ParticipantsTreatment Effectiveness by MonthMonth 82.3 score on a scaleStandard Deviation 1.08
All ParticipantsTreatment Effectiveness by MonthMonth 92.3 score on a scaleStandard Deviation 1.09

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026